Manabu Kurokawa

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 9

Top Topics

Cell Proliferation

Immune Response

Childhood Cancer

Top Venues

International journal of molecular sciences

Molecular cancer research : MCR

Scientific reports

This page only lists publications with an associated author ORCID identifier.

Publications

William W Feng, Hannah T Zuppe, Manabu Kurokawa
The Role of CD36 in Cancer Progression and Its Value as a Therapeutic Target. Cells 12 (12) (2023)
William W Feng, Hannah T Zuppe, Manabu Kurokawa
The Role of CD36 in Cancer Progression and Its Value as a Therapeutic Target. Cells 12 (12) (2023)
William W Feng, Hannah T Zuppe, Manabu Kurokawa
The Role of CD36 in Cancer Progression and Its Value as a Therapeutic Target. Cells 12 (12) (2023)
Sandeep Kaur, Manabu Kurokawa
Regulation of Oocyte Apoptosis: A View from Gene Knockout Mice. International journal of molecular sciences 24 (2) (2023)
Sandeep Kaur, Manabu Kurokawa
Regulation of Oocyte Apoptosis: A View from Gene Knockout Mice. International journal of molecular sciences 24 (2) (2023)
Sandeep Kaur, Manabu Kurokawa
Regulation of Oocyte Apoptosis: A View from Gene Knockout Mice. International journal of molecular sciences 24 (2) (2023)
Evelien Schaafsma, Eric M Takacs, Sandeep Kaur, Chao Cheng, Manabu Kurokawa
Predicting clinical outcomes of cancer patients with a p53 deficiency gene signature. Scientific reports 12 (1) (2022)
Katie L Pennington, Colten M McEwan, James C Woods, Colin M Muir, A G Pramoda Sahankumari, Riley Eastmond, Eranga Roshan Balasooriya, Christina M Egbert, Sandeep Kaur, Tyler Heaton, Katherine K McCormack, Stephen R Piccolo, Manabu Kurokawa, Joshua L Andersen
SGK2, 14-3-3, and HUWE1 Cooperate to Control the Localization, Stability, and Function of the Oncoprotein PTOV1. Molecular cancer research : MCR (2021)
William W Feng, Scott Bang, Manabu Kurokawa
CD36: a key mediator of resistance to HER2 inhibitors in breast cancer. Molecular & cellular oncology 7 (2) (2020)